#EyeYon Medical

[blueweave]

China Ophthalmic Surgical Instruments Market size at USD 1.98 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the China Ophthalmic Surgical Instruments Market size to expand at a CAGR of 12.88% reaching a value of USD 3.11 billion by 2030. The China Ophthalmic Surgical Instruments Market is propelled by the increasing prevalence of eye-related conditions, such as glaucoma and cataracts, coupled with a broader spectrum of vision-related issues in the country. The market growth is further propelled by the ongoing development of advanced healthcare infrastructure on a global scale. A notable rise in the elderly population and government initiatives aimed at enhancing awareness regarding visual impairments significantly contribute to the overall market upswing. Also, ongoing innovations and advancements in ophthalmic devices, such as those integrating smartphones and leveraging sophisticated ophthalmic microscopes for clearer visualization, are expected to create lucrative growth opportunities for the players in the China Ophthalmic Surgical Instruments Market.

Opportunity – Advancements in technology

Cutting-edge devices and techniques hold the potential to enhance outcomes for individuals grappling with incurable conditions. Ophthalmologists, employing advanced technology across subspecialties, have witnessed significant progress. The continual evolution of diagnostic and ophthalmic devices proves crucial for treatment, fostering competition among market players vying for market dominance. Research and development initiatives in various medical institutions in China promise growth opportunities. Sponsored projects, often in collaboration with medical organizations and market players, pave the way for innovations. Key industry players strategically drive market growth through initiatives like product launches, approvals, and research. For instance, EyeYon Medical's EndoArt, granted Innovative Device Status by China's Center for Medical Device Evaluation, stands out as a groundbreaking ophthalmic device, holding both Chinese and United States designations. Recognized for treating chronic corneal edema, its early approval underscores the industry's commitment to advancing technology for more effective treatment of life-threatening conditions.

Sample Request @ https://www.blueweaveconsulting.com/report/china-ophthalmic-surgical-instruments-market/report-sample

[techsciresearch]

Artificial Cornea and Corneal Implants Market to grow at an Impressive CAGR During the Forecast Period | TechSci Research

Increasing prevalence of ophthalmic diseases is supporting the growth of Global Artificial Cornea and Corneal Implants Market.

According to TechSci Research report, “Global Artificial Cornea and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, the global artificial cornea and corneal implants market is anticipated to show robust growth in the upcoming five years owing to the major factors like rising population of the old people. Older population have a tendency of contracting various high-risk eye diseases, also vision impairment and corneal rupture is quite frequent in the geriatric population, supporting the growth of global artificial cornea and corneal implants market in the next five years.

Moreover, organizations like Eye Bank Association of America (EBAA) and The Global Alliance of Eye Bank Associations are creating a lot of awareness and are promoting policies regarding effective corneal transplantation and encouraging the patients to choose the procedure. This factor is actively supporting the global artificial cornea and corneal implants market growth in the next five years. Additionally, the market experiences a surge in demand of non-invasive or minimally invasive procedure for various medical diagnostic and surgical requirements thereby boosting the growth of global artificial cornea and corneal implants market from 2022 to 2026.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Artificial Cornea and Corneal Implants Market"

https://www.techsciresearch.com/report/artificial-cornea-and-corneal-implants-market/7608.html

The global artificial cornea and corneal implants market is segmented by type, transplantation type, disease indication, end user, competitional landscape and regional distribution. Based on transplantation type the market is further segmented into penetrating keratoplasty v/s endothelial keratoplasty. Penetrating keratoplasty is the dominant market segment with the largest shares in the historical period. Penetrating keratoplasty is also anticipated to assert its dominance over the market in the upcoming five years, owing its growth to the safety and efficiency of the procedure. Although the market segment faces a minor threat from its alternate procedure; endothelial keratoplasty.

Endothelial keratoplasty is anticipated to record fastest growth in the upcoming market owing its growth to the promising results the procedure shows. The endothelial keratoplasty is the latest approach in the market and involves minimal invasion like it only replaces the affected tissue rather than the complete cornea. Availability of the human cornea for the replacement is an issue that becomes null and void because of the efficiency of the endothelial keratoplasty procedure. Moreover, the procedure helps with the faster and better visual restoration with decreased risk of eye infection and any pother accidental mishaps during procedure. Also, growing prevalence of Fuchs dystrophy is anticipated to support the robust growth of the market segment.

Based on disease indication, the market is further bifurcated into Fuchs’ dystrophy, keratoconus, fungal keratitis, and others. Rising geriatric population is quite susceptible to contracting Fuchs’ dystrophy. The disease held the largest as well as the fastest growing market share. It is anticipated to assert its dominance in the forecast period too. Keratoconus disease held the significant share of market too, rising number of the patient suffering from keratoconus often reach the stage where they require corneal implant to regain their normal vision. Advanced procedures like Deep Anterior Lamellar Keratoplasty (DALK) bestows the advantage, the factor, along with FDA approved corneal implants are major drivers of the market growth in the forecast period.

Top players of the market are F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc, Alcon, Inc., Bayer AG, Bausch & Lomb Incorporated, AJL Ophthalmic S.A., CorneaGen Inc., Addition Technology, Inc., LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab (Aravind Eye Care System), LinCor Biosciences, Pte. Ltd. (Cornea Biosciences), DIOPTEX GmbH, EyeYon Medical Ltd.., among others. Other strategies include partnerships among the players and technologically advanced product launches.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7608

Customers can also request for 10% free customization on this report.

“Major players of the market are headquartered in the North American region. The efficient reimbursement policies by the government of large economies like United States in the region, make North America the dominating sector for the market. Moreover, the players are actively involved in the research and development of the implants and efficient processes thereby supporting the market growth in the forecast period. Asia Pacific region is expected to be fastest growing market. New markets in the developing countries are emerging and the cost-effective procedures in these countries would help strengthen the market in countries like China, Indonesia, Philippines,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Artificial Cornea and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global artificial cornea and corneal implants and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global artificial cornea and corneal implants.

Browse Related Reports:

Global Autoinjectors Market By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others) By Design (Standardized v/s Customized) By Product (Prefilled v/s Fillable) By Technology (Automated v/s Manual) By Type (Disposable v/s Reusable) By Route of Administration (Intravenous v/s Subcutaneous) By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings) By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/autoinjectors-market/7341.html

Global Foot & Ankle Devices Market By Product Type (Joint Implants, Fixation Devices, Soft Tissue Orthopedic Devices, Bracing & Support Devices, Prostheses) By Procedure (Osteotomy, Fracture Repair, Fusion Procedures, Others) By Application (Trauma & Hair line Fractures, Rheumatoid Arthritis & Osteoarthritis, Diabetic Foot Diseases, Ligament Injuries, Others) By End User (Hospitals, Ambulatory Surgery Centers, Orthopedic Clinics, Rehabilitation Centers) By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/foot-and-ankle-devices-market/7342.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

[techscimarketresearch]

Artificial Cornea and Corneal Implants Market to grow at an Impressive CAGR During the Forecast Period | TechSci Research

Increasing prevalence of ophthalmic diseases is supporting the growth of Global Artificial Cornea and Corneal Implants Market.

According to TechSci Research report, “Global Artificial Cornea and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, the global artificial cornea and corneal implants market is anticipated to show robust growth in the upcoming five years owing to the major factors like rising population of the old people. Older population have a tendency of contracting various high-risk eye diseases, also vision impairment and corneal rupture is quite frequent in the geriatric population, supporting the growth of global artificial cornea and corneal implants market in the next five years.

Moreover, organizations like Eye Bank Association of America (EBAA) and The Global Alliance of Eye Bank Associations are creating a lot of awareness and are promoting policies regarding effective corneal transplantation and encouraging the patients to choose the procedure. This factor is actively supporting the global artificial cornea and corneal implants market growth in the next five years. Additionally, the market experiences a surge in demand of non-invasive or minimally invasive procedure for various medical diagnostic and surgical requirements thereby boosting the growth of global artificial cornea and corneal implants market from 2022 to 2026.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Artificial Cornea and Corneal Implants Market"

https://www.techsciresearch.com/report/artificial-cornea-and-corneal-implants-market/7608.html

The global artificial cornea and corneal implants market is segmented by type, transplantation type, disease indication, end user, competitional landscape and regional distribution. Based on transplantation type the market is further segmented into penetrating keratoplasty v/s endothelial keratoplasty. Penetrating keratoplasty is the dominant market segment with the largest shares in the historical period. Penetrating keratoplasty is also anticipated to assert its dominance over the market in the upcoming five years, owing its growth to the safety and efficiency of the procedure. Although the market segment faces a minor threat from its alternate procedure; endothelial keratoplasty.

Endothelial keratoplasty is anticipated to record fastest growth in the upcoming market owing its growth to the promising results the procedure shows. The endothelial keratoplasty is the latest approach in the market and involves minimal invasion like it only replaces the affected tissue rather than the complete cornea. Availability of the human cornea for the replacement is an issue that becomes null and void because of the efficiency of the endothelial keratoplasty procedure. Moreover, the procedure helps with the faster and better visual restoration with decreased risk of eye infection and any pother accidental mishaps during procedure. Also, growing prevalence of Fuchs dystrophy is anticipated to support the robust growth of the market segment.

Based on disease indication, the market is further bifurcated into Fuchs’ dystrophy, keratoconus, fungal keratitis, and others. Rising geriatric population is quite susceptible to contracting Fuchs’ dystrophy. The disease held the largest as well as the fastest growing market share. It is anticipated to assert its dominance in the forecast period too. Keratoconus disease held the significant share of market too, rising number of the patient suffering from keratoconus often reach the stage where they require corneal implant to regain their normal vision. Advanced procedures like Deep Anterior Lamellar Keratoplasty (DALK) bestows the advantage, the factor, along with FDA approved corneal implants are major drivers of the market growth in the forecast period.

Top players of the market are F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc, Alcon, Inc., Bayer AG, Bausch & Lomb Incorporated, AJL Ophthalmic S.A., CorneaGen Inc., Addition Technology, Inc., LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab (Aravind Eye Care System), LinCor Biosciences, Pte. Ltd. (Cornea Biosciences), DIOPTEX GmbH, EyeYon Medical Ltd.., among others. Other strategies include partnerships among the players and technologically advanced product launches.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7608

Customers can also request for 10% free customization on this report.

“Major players of the market are headquartered in the North American region. The efficient reimbursement policies by the government of large economies like United States in the region, make North America the dominating sector for the market. Moreover, the players are actively involved in the research and development of the implants and efficient processes thereby supporting the market growth in the forecast period. Asia Pacific region is expected to be fastest growing market. New markets in the developing countries are emerging and the cost-effective procedures in these countries would help strengthen the market in countries like China, Indonesia, Philippines,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Artificial Cornea and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global artificial cornea and corneal implants and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global artificial cornea and corneal implants.

Browse Related Reports:

Global Autoinjectors Market By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others) By Design (Standardized v/s Customized) By Product (Prefilled v/s Fillable) By Technology (Automated v/s Manual) By Type (Disposable v/s Reusable) By Route of Administration (Intravenous v/s Subcutaneous) By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings) By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/autoinjectors-market/7341.html

Global Foot & Ankle Devices Market By Product Type (Joint Implants, Fixation Devices, Soft Tissue Orthopedic Devices, Bracing & Support Devices, Prostheses) By Procedure (Osteotomy, Fracture Repair, Fusion Procedures, Others) By Application (Trauma & Hair line Fractures, Rheumatoid Arthritis & Osteoarthritis, Diabetic Foot Diseases, Ligament Injuries, Others) By End User (Hospitals, Ambulatory Surgery Centers, Orthopedic Clinics, Rehabilitation Centers) By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/foot-and-ankle-devices-market/7342.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

[sandlerresearch]

Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026 published on

https://www.sandlerresearch.org/artificial-cornea-and-corneal-implant-market-by-type-human-cornea-artificial-cornea-transplant-type-penetrating-keratoplasty-endothelial-keratoplasty-disease-indication-end-users-hospitals.html

Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026

The artificial cornea and corneal implant market is expected to grow at a CAGR of 7.4% in the forecast period.

The global artificial cornea and corneal implant market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026. Market growth is largely driven by the The growing geriatric population and the rising prevalence of eye diseases are the major drivers for the artificial cornea and corneal implants market. The increasing prevalence of eye disorders and government initiatives to control visual impairment are further boosting the market growth.

However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of this market during the forecast period.

 “Human cornea segment accounted for the largest share of artificial cornea and corneal implant market in 2020”

On the basis of type, the artificial cornea and corneal implants market is segmented into human cornea and artificial cornea. In 2020, the human cornea segment accounted for the largest share of the artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising awareness regarding corneal transplantation and eye tissue donations, especially in developing economies.

“Penetrating keratoplasty segment accounted for the largest share of artificial cornea and corneal implant market in 2020”

On the basis of transplant type, the artificial cornea and corneal implants market is segmented into penetrating keratoplasty, endothelial keratoplasty, and other transplants (including anterior lamellar keratoplasty (ALK) and keratoprosthesis). In 2020, the penetrating keratoplasty segment accounted for the largest share of the global artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball.

 “North America accounted for the largest share of the artificial cornea and corneal implant market in 2020.”

Geographically, the artificial cornea and corneal implant market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. In 2020, North America accounted for the largest share of the global artificial cornea and corneal implants market. The market is well-established in North America, with the US dominating the market in this region. The large share of North America is mainly attributed to the established healthcare infrastructure, higher adoption of sophisticated healthcare technologies, higher budget among end users of ophthalmic devices, and a large number of manufacturers for corneal implants in the region.

By Company: Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%

By Designation: C-level Executives: 25%, Directors: 55%, and Others: 20%

By Region: North America: 40%, Europe: 25%, APAC: 20%, LATAM: 10% and MEA: 5%

Some of the key players in the artificial cornea and corneal implant market are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US), L V Prasad Eye Institute (LVPEI, India), New Mexico Lions Eye Bank (NMLEB, US), San Antonio Eye Bank (US), Kansas Eye Bank & Cornea Research Center (US), Rocky Mountain Lions Eye Bank (US), Netherlands Institute for Innovative Ocular Surgery (NIIOS, Netherlands), CTS Eye Bank (UK), The East Anglian Eye Bank (UK), Kensington Health (Canada), and Beijing Tongren Eye Bank (China). The study includes an in-depth competitive analysis of these key players in the artificial cornea and corneal implant market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the artificial cornea and corneal implant market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, transplant type, disease indication, end users and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the artificial cornea and corneal implant market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide information on key market drivers, restraints, opportunities and challenges.

[vybas]

Israeli startup receives CE Mark for synthetic corneal implant

Israeli startup receives CE Mark for synthetic corneal implant

Israeli ophthalmology startup, EyeYon Medical, has received a CE Mark for its flagship product EndoArt, the world’s first synthetic corneal implant designed to counteract corneal edema. Edema is the excess build-up of fluids in the cornea caused by damaged endothelial cells, which usually regulate hydration levels in the eye. It can result in irreversible scarring, pain and even…

[rohinic123-blog]

Artificial Iris Market  Set to Garner Staggering Revenues by 2027

Artificial Iris market: Therapeutic Option for Aniridia and Other Eye Conditions

Artificial iris is a prosthetic iris (the colored part of the eye around the pupil) made of thin, foldable medical-grade silicone

The device is custom-made and can be sized and colored for each individual patient as per his/her requirement. Artificial iris can be used to treat congenital (genetic disorder in which the iris is completely or partially absent) and traumatic aniridia.

It can also be used to treat iris defects caused due to other reasons or conditions such as albinism or surgical removal due to melanoma

High adoption of artificial iris implant is because it is a minimally invasive procedure, wherein the iris can be implanted with very small incision or surgical injector

The artificial iris itself does not cure or treat the condition, but helps to improve the condition and quality of life. Artificial iris also improves cosmetic appearance of the eye and visual symptoms.

Planning To Lay Down Future Strategy? Request Brochure Of Artificial Iris Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76295

Key Drivers and Restraints of Global Artificial Iris Market

Increase in incidence rate of eye defects such as congenital aniridia, cosmetic issues, and traumatic iris loss is the major factor boosting the growth of the global artificial iris market

An article published by NCBI stated that aniridia is detected in around 1.8/100,000 live births each year and the incidence ranges from 1:40,000 to 1:100,000 globally

Rise in number of clinical trials aimed at development of advanced products for treatment of various eye defects is the major factor propelling the global artificial iris market

Moreover, recent regulatory approval for artificial iris implant and growing concerns about improvement of cosmetic appearance of the eye are the other drivers of the global artificial iris market

Regulatory Restrictions for Use of Artificial Iris Implants to Hamper Market Growth

Artificial iris is still a new concept and approved in limited countries for use due to regulatory restrictions for its application. This factor is projected to restrain the global artificial iris market.

Side effects associated with implant procedure also hampers the growth of the global artificial iris market

To Obtain All-Inclusive Information On Forecast Analysis Of Artificial Iris Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=76295

Fiber Free Segment Accounted for Major Market Share

Based on material, the global artificial iris market can be bifurcated into fiber and fiber free

The fiber free segment dominated the global artificial iris market in 2018 owing to its feasibility for suture-less implant techniques

The fiber segment is expected to expand at a higher CAGR during the forecast period due to the property of fiber to provide adequate tear strength to withstand suturing because of a polyester meshwork layer embedded to it.

Adult Segment Dominated Global Market

In terms of age group, the global artificial iris market can be divided into adult and pediatric

The adult segment accounted for major market share in 2018. The trend is anticipated to continue during the forecast period owing to large adult population suffering from various eye defects and increase in geriatric population, which is more prone to eye disorders.

Blue to be Highly Lucrative Segment

Based on color, the global artificial iris market can be classified into blue, brown, and others

The blue segment dominated the global market in 2018 due to higher preference for this color of iris among people who undergo cosmetic surgery. It is expected to be a highly promising segment during the forecast period owing to rise in cosmetic procedures across the world.

Therapeutic Segment held Significant Share of Global Market

In terms of application, the global artificial iris market can be bifurcated into therapeutic and cosmetic

The therapeutic segment is likely to account for major share of the global market during the forecast period owing to increase in population suffering from traumatic iris defects and regulatory approvals for artificial iris for therapeutic application in the past few years

Specialty Clinics to be Highly Promising Segment

Based on end-user, the global artificial iris market can be classified into hospitals, specialty clinics, and others

The hospitals segment dominated the global market in 2018 owing to rise in number of ophthalmic procedures and availability of better facilities at these settings

Specialty clinics is likely to be a highly lucrative segment during the forecast period owing to rise in preference of people for specialized care for their health problems and availability of advanced products for treatment of a particular condition at specialty clinics.

Europe to Lead Global Artificial Iris Market

In terms of region, the global artificial iris market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Europe dominated the global artificial iris market in 2018 due to higher number of artificial iris implant surgeries, presence of major companies, people preference for cosmetic procedures for eye color change, and availability of artificial iris implants since many years.

An article in Healthline Media stated that people in Europe have the widest variety of eye colors. Their eyes range from dark brown to light blue. In general, they have the lightest eye colors.

North America was the next dominant region in terms of market share in 2018. The market in the region is expected to witness significant growth in the next few years due to the U.S. FDA approval for world’s first artificial iris, CustomFlex, increase in incidence of eye defects, and rise in inclination toward minimally invasive eye surgery.

Asia Pacific is projected to be a highly lucrative market during the forecast period owing to increase in geriatric population and rise in health care facilities

Key Players Operating in Global Artificial Iris Market

Leading players operating in the global market are:

HumanOptics AG

Morcher GmbH

Ophtec BV

EyeYon Medical

Spectrum Surgical

Reper-NN Ltd.

VEO Ophthalmics, LLC.

Pixium Vision

More Trending Reports by Transparency Market Research –

Lithotripsy Device Market –

https://www.prnewswire.com/news-releases/increasing-prevalence-of-kidney-stones-to-drive-growth-of-global-lithotripsy-device-market-to-valuation-worth-us0-98-bn-by-2026-end-transparency-market-research-301003584.html

Request For Coronavirus Infection Market Analysis –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16940